儿童重症哮喘中肺2型固有淋巴细胞表型及对激素的反应
该研究对儿童重症难治性哮喘(STRA)、困难性哮喘(DA)及非哮喘对照进行痰和血ILC与T细胞免疫表型分析,并在STRA患儿中纵向观察肌注曲安奈德前后变化。STRA气道嗜酸性粒细胞、Th2细胞和ILC2显著高于DA和疾病对照,全身激素后ILC2和Th2显著减少且症状与急性发作改善,但IL-17+细胞和嗜酸性粒细胞持续存在。
要点
- 儿童STRA与DA气道分子表型不同,STRA以2型细胞升高为特征。
- 全身激素可减少ILC2和Th2并改善症状与急性发作。
- IL-17+淋巴细胞和嗜酸性粒细胞在全身激素后持续存在。
核心结论
- 儿童STRA和DA具有不同的气道分子表型,STRA以2型细胞升高为特征。
- 全身糖皮质激素而非维持吸入激素可改善症状控制和急性发作,伴功能性ILC2减少,但IL-17+淋巴细胞持续升高。
研究设计与样本
- 对STRA、DA和非哮喘对照的痰和血ILC及T细胞进行免疫表型分析。
- 对STRA患儿在肌注曲安奈德前后纵向分析白细胞。
- 体外培养ILC评估激素反应性。
主要发现
- STRA患者气道嗜酸性粒细胞、Th2细胞和ILC2显著高于DA和疾病对照。
- IL-17+淋巴细胞在各组间相似。
- 肌注曲安奈德后ILC2和Th2细胞显著减少,体外激素亦减少。
- 全身激素后哮喘急性发作和症状减少,但IL-17+细胞和嗜酸性粒细胞持续存在。
临床怎么用
- 儿童STRA应识别2型炎症表型,全身激素可减少ILC2并改善症状控制。
- 全身激素后需关注IL-17+淋巴细胞和嗜酸性粒细胞持续存在,提示部分激素抵抗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children with severe therapy-resistant asthma (STRA) have poor control despite maximal treatment, while those with difficult asthma (DA) have poor control from failure to implement basic management, including adherence to therapy. Although recognised as clinically distinct, the airway molecular phenotype, including the role of innate lymphoid cells (ILCs) and their response to steroids in DA and STRA is unknown.Immunophenotyping of sputum and blood ILCs and T-cells from STRA, DA and non-asthmatic controls was undertaken. Leukocytes were analysed longitudinally pre- and post-intramuscular triamcinolone in children with STRA. Cultured ILCs were evaluated to assess steroid responsiveness in vitroAirway eosinophils, type 2 T-helper (Th2) cells and ILC2s were significantly higher in STRA patients compared to DA and disease controls, while IL-17+ lymphoid cells were similar. ILC2s and Th2 cells were significantly reduced in vivo following intramuscular triamcinolone and in vitro with steroids. Furthermore, asthma attacks and symptoms reduced after systemic steroids despite persistence of steroid-resistant IL-17+ cells and eosinophils.Paediatric STRA and DA have distinct airway molecular phenotypes with STRA characterised by elevated type-2 cells. Systemic corticosteroids, but not maintenance inhaled steroids resulted in improved symptom control and exacerbations concomitant with a reduction in functional ILC2s despite persistently elevated IL-17+ lymphoid cells.
引用
- Nagakumar P, Puttur F, Gregory LG, et al. Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids. Eur Respir J. 2019. PMID: 31164437. doi:10.1183/13993003.01809-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。